Educational Background

College of Medicine-MD, Yonsei University (3/1988 - 2/1994)

Graduate School of Medicine- MS, Yonsei University (9/1996 - 8/1998)

Graduate School of Medicine- PhD, Yonsei University (3/2002 – 8/2009)

Professional Career

3/2003 – present Professor of Cardiovascular Medicine, Gachon University College of Medicine

9/2011– 8/2012 Visiting Associate Professor, Stanford University School of Medicine, Stanford, CA, USA

3/2017 – present Director, Gachon Cardiovascular Research Institute, Gachon University

5/2017 – 11/2022 Editor-in-Chief, Clinical Hypertension

1/2022 – 6/2024 Director, Office of Planning and Coordination, Gachon University Gil Medical Center

1/2021 – present President, Korean Society of Pulmonary Hypertension

3/2024 - present Chair, Planning Committee, Korean Society of Heart Failure

7/2024 – present Vice President, Gachon University Gil Medical Center

1/2025 - present Chair, Policy Committee, Korean Society of Cardiology

Research Field

His research interests primarily focus on pulmonary hypertension, heart failure, cardiac imaging including innovative device developments and medical education. His approach has deepened the understanding of pathophysiology leading to translational deep phenotyping and therapeutic options in pulmonary hypertension and heart failure. Also, he serves as President of Korean Pulmonary Hypertension Society (2021~), Chair of Planning Committee of Korean Heart Failure Society (2024~), Chair of Policy Committee of Korean Society of Cardiology (2025~) and Editor-in-Chief of Right Heart Journal (2025~), the offical journal of EASOPH.

Papers, Books, etc. presented or published by your name

13 Books and 165 peer-reviewed articles (103 SCI(E) Journals, 54 first and corresponding authors)
http://orcid.org/0000-0002-9767-7098
Scopus author ID: 36723733700
Web of Science Researcher ID: AAJ-5613-2021

Educational Background

Prof. Dr. med. Stephan Rosenkranz completed his Doctoral dissertation at Justus-Liebig-Universität Gießen, Gießen, Germany; a Post-doctoral fellowship at Harvard Medical School, Boston, Massachusetts, USA; and a residency and research fellowship at the Klinik III für Innere Medizin (Dept. of Cardiology), University of Cologne, Germany.

Professional Career

Prof. Dr. med. Stephan Rosenkranz currently holds the posts of Chair, Cologne Cardiovascular Research Center (CCRC); Full Professor of Cardiology (“Cardiopulmonary interaction”), University of Cologne; Head of Expert Center on Pulmonary Hypertension; Associate editor of European Journal of Heart Failure, Cardiovascular Research, Current Heart Failure Reports; and as a reviewer for numerous scientific journals, including Journal of the American Medical Association, Lancet, European Heart Journal.

Research Field

Prof. Dr. med. Stephan Rosenkranz has experience in numerous clinical trials in the field of heart failure and pulmonary hypertension (phase I, II, III, IV) and is Head ("Principal Investigator") of the working group on "Molecular Cardiology," with a research focus of Signal transduction and pathobiological relevance of tyrosine kinases in cardiovascular disease.

Papers, Books, etc. presented or published by your name

Most recently: Rosenkranz S, Ghofrani HA, Hoeper MM, et al. Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities:
Data from interventional clinical trials [published correction appears in J Heart Lung Transplant.
2025:S1053-2498(25)01764-4. doi: 10.1016/j.healun.2025.02.1679.]. J Heart Lung Transplant. 2025;44(2):135-146. doi:10.1016/j.healun.2024.08.018

Educational Background

2004-2006 Postdoctoral Fellow, ANTOINE BECLERE Hospital, Université Paris-Sud (Paris XI, South Paris University), France

1994-1998 Doctor of Medicine (M.D.) in Internal Medicine (Cardiovascular Diseases), Peking Union Medical College (PUMC), China

1989-1994 Bachelor of Medicine (M.B.) in Clinical Medicine, Weifang Medical University, China

Professional Career

Zhi-Cheng Jing is Full Professor of Medicine, the Director of Cardiology Department in Guangdong Provincial People’s Hospital and the Vice-president of Guangdong Cardiovascular Institute. He is the Associate Editor of Journal of Thrombosis and Haemostasis, the Associate Editor of Heart, the Asia-Pacific Regional Editor of JACC, the deputy editor in chief of Chinese Journal of Cardiology, and the Section Editor of JACC Asia.

Research Field

Pulmonary Hypertension (PH)

Pulmonary Hypertensive Crisis

Pulmonary Embolism (PE)

Right Heart Circulation

Congenital Heart Disease (CHD)

Papers, Books, etc. presented or published by your name

1. Zhou YP, Wei YP, Yang YJ, et al. Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension. J Am Coll Cardiol. 2022;79(15):1477-1488.

2. Zhang ZJ, Liu C, Ma JL, et al. Prognostic Value of Plasma Immunoglobulin G N-Glycome Traits in Pulmonary Arterial Hypertension. J Am Coll Cardiol. 2024;84(12):1092-1103.

3. Wu XH, He YY, Chen ZR, et al. Single-cell analysis of peripheral blood from high-altitude pulmonary hypertension patients identifies a distinct monocyte phenotype. Nat Commun. 2023;14(1):1820. Published 2023 Mar 31.

4. Yan Y, He YY, Jiang X, et al. DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension. Sci Adv. 2020;6(50):eaba2470. Published 2020 Dec 9.